These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1018 related articles for article (PubMed ID: 18701763)
1. Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Russo G; Haddad R; Posner M; Machtay M Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763 [TBL] [Abstract][Full Text] [Related]
2. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. Rosenthal DI J Support Oncol; 2007 Oct; 5(9 Suppl 4):23-31. PubMed ID: 18046995 [TBL] [Abstract][Full Text] [Related]
3. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169 [TBL] [Abstract][Full Text] [Related]
4. [Radiation-induced mucositis and neutrophil granulocytes in oral mucosa]. Schmidberger H; Rave-Fränk M; Kim S; Hille A; Pradier O; Hess CF Strahlenther Onkol; 2003 Oct; 179(10):667-72. PubMed ID: 14566474 [TBL] [Abstract][Full Text] [Related]
5. Mucositis: biology and management. Treister N; Sonis S Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):123-9. PubMed ID: 17413415 [TBL] [Abstract][Full Text] [Related]
6. Impact of dose and volume on radiation-induced mucositis. Mantini G; Manfrida S; Cellini F; Giammarino D; Petrone A; Vitucci P; Cellini N Rays; 2005; 30(2):137-44. PubMed ID: 16294906 [TBL] [Abstract][Full Text] [Related]
7. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences]. Dietz A; Nollert J; Maier H; Rudat V; Flentje M HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657 [TBL] [Abstract][Full Text] [Related]
8. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. Murphy BA J Support Oncol; 2007 Oct; 5(9 Suppl 4):13-21. PubMed ID: 18046994 [TBL] [Abstract][Full Text] [Related]
9. Head and neck squamous cell carcinoma: optimizing the therapeutic index. Rosenthal DI; Blanco AI Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957 [TBL] [Abstract][Full Text] [Related]
10. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228 [TBL] [Abstract][Full Text] [Related]
11. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial. Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945 [TBL] [Abstract][Full Text] [Related]
12. [Can the prophylactic treatment of mycotic mucositis improve the time of performing radiotherapy in head and neck tumors?]. Gava A; Ferrarese F; Tonetto V; Coghetto F; Marazzato G; Zorat PL Radiol Med; 1996 Apr; 91(4):452-5. PubMed ID: 8643858 [TBL] [Abstract][Full Text] [Related]
13. Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial. Skladowski K; Maciejewski B; Golen M; Tarnawski R; Slosarek K; Suwinski R; Sygula M; Wygoda A Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):706-13. PubMed ID: 17011446 [TBL] [Abstract][Full Text] [Related]
14. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study. Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585 [TBL] [Abstract][Full Text] [Related]
15. Strategies for managing radiation-induced mucositis in head and neck cancer. Rosenthal DI; Trotti A Semin Radiat Oncol; 2009 Jan; 19(1):29-34. PubMed ID: 19028343 [TBL] [Abstract][Full Text] [Related]
16. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553 [TBL] [Abstract][Full Text] [Related]
18. Mucositis: current management and investigations. Garden AS Semin Radiat Oncol; 2003 Jul; 13(3):267-73. PubMed ID: 12903015 [TBL] [Abstract][Full Text] [Related]
19. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161 [TBL] [Abstract][Full Text] [Related]